Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockBearish
3
Neutral
9
Bullish
2
Bearish
24
Neutral
13
Bullish
9
Bearish
21
Neutral
4
Bullish
7
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Caprolactam Chemicals Ltd specializes in chemical manufacturing and offers contract manufacturing services across various sectors such as flavors, fragrance, aroma, pharma, and agrochemicals.
Originally established as a sick company in 2001 due to financial challenges, Caprolactam Chemical's financial health improved gradually, enabling its exit from the sick company list by 2006.
The company operates a state-of-the-art manufacturing facility located near Mumbai, which supports its contract manufacturing offerings and enhances its ability to quickly commercialize products.
Caprolactam Chemicals leverages a skilled management and technical team, enhancing its ability to deliver efficient contract manufacturing without significant investment in separate infrastructure.
The company plays a supportive role for clients requiring contract manufacturing services, potentially reducing their costs in terms of infrastructure, staffing, and equipment investments.
Chemicals & Petrochemicals
Commodity Chemicals
22 Cr
Low Risk
12.4
42.5
-0.0
3.4
81.00
38.10
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Caprolactam Chemicals Ltd (CAPRO) is currently trading at 47.88 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Caprolactam Chemicals Ltd specializes in chemical manufacturing and offers contract manufacturing services across various sectors such as flavors, fragrance, aroma, pharma, and agrochemicals. Originally established as a sick company in 2001 due to financial challenges, Caprolactam Chemical's financial health improved gradually, enabling its exit from the sick company list by 2006. The company operates a state-of-the-art manufacturing facility located near Mumbai, which supports its contract manufacturing offerings and enhances its ability to quickly commercialize products. Caprolactam Chemicals leverages a skilled management and technical team, enhancing its ability to deliver efficient contract manufacturing without significant investment in separate infrastructure. The company plays a supportive role for clients requiring contract manufacturing services, potentially reducing their costs in terms of infrastructure, staffing, and equipment investments.
Over the past 52 weeks, Caprolactam Chemicals Ltd has traded between a low of ₹38.10 and a high of ₹81.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Caprolactam Chemicals Ltd has a market capitalization of approximately 22.02. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Caprolactam Chemicals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 12.44 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 22.02 Cr, Caprolactam Chemicals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Caprolactam Chemicals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Caprolactam Chemicals Ltd is 12.44. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
57.23 | 24 Cr | 34.84 | 0.87 | 0.00 | 2.50 | 6.79 | 0.84 | ||
54.50 | 24 Cr | 6.86 | 0.64 | 0.00 | 9.30 | 12.50 | 8.57 | ||
9.25 | 23 Cr | 18.47 | 1.75 | 0.00 | 9.33 | 10.80 | 2.95 | ||
47.88 | 22 Cr | 12.44 | 3.35 | 0.00 | 26.76 | 18.25 | 10.39 | ||
33.58 | 21 Cr | 105.25 | 2.17 | 0.00 | 2.10 | 2.10 | 2.12 | ||
8.07 | 19 Cr | -3.82 | 0.00 | 0.00 | 3.71 | -72.69 | -7.06 | ||
9.68 | 18 Cr | -43.69 | 0.00 | 0.00 | 2.27 | 7.39 | -9.70 | ||
| Median: 7 Co. | — | 33.58 | 22 Cr | 12.44 | 0.87 | 0.00 | 3.71 | 7.39 | 2.12 |
Board Meeting
Caprolactam Chemicals Ltd notified that its Board will meet on 2026-08-13 to consider and approve unaudited financial results for quarter ended June 30, 2026; trading window closed from July 1, 2026.
Board Meeting
Caprolactam Chemicals Ltd will hold a Board meeting on 2026-08-13 to consider and approve unaudited financial results for quarter ended June 30, 2026; trading window closed from 2026-07-01.
